C-diff infection 4 times more likely to kill patients with inflammatory bowel diseaseSeptember 27, 2007Excess hospitalization burden associated with Clostridium difficile in patients with inflammatory bowel disease Clostridium difficile infection is four times more likely to kill patients with inflammatory bowel disease, suggests research published ahead of print in the journal Gut. C difficile is an important cause of diarrhoea among inpatients, and the numbers of new cases of the infection have been steadily increasing in recent years.
The findings are based on a representative sample of community hospital admissions in the US for 2003. The sample covered 994 hospitals in 37 States and included a total of 124,570 patients. Of these, 44,400 had been admitted with C difficile infection, and 77,366 had been admitted with inflammatory bowel disease (Crohn's disease or ulcerative colitis), or IBD for short. A further 2,804 had both IBD and C difficile infection. Those with the infection alone tended to be considerably older, and had an average age of 73. Those with IBD had an average age of 42. The risk of death was higher among those with C difficile infection alone or in combination with IBD than it was in those with IBD alone. But patients with both the infection and IBD were four times more likely to die than patients with just IBD or C difficile infection alone, irrespective of age. Patients with the combination also stayed in hospital three days longer and had higher rates of endoscopy, a procedure in which a long tube with a camera on the end is passed through the gut. Patients with ulcerative colitis had more severe C difficile infection than those with Crohn's disease and worse outcomes. The authors conclude that patients with IBD may be particularly susceptible to infection with C difficile. BMJ Specialty Journals | |||||||||||||||||||||
|
Related Inflammatory Bowel Disease News Articles Bone marrow stem cells may help control inflammatory bowel disease Massachusetts General Hospital (MGH) investigators have found that infusions of a particular bone marrow stem cell appeared to protect gastrointestinal tissue from autoimmune attack in a mouse model. Biodegradable polymers show promise for improving treatment of acute inflammatory diseases A family of biodegradable polymers called polyketals and their derivatives may improve treatment for such inflammatory illnesses as acute lung injury, acute liver failure and inflammatory bowel disease by delivering drugs, proteins and snips of ribonucleic acid to disease locations in the body. Obesity raises risks of serious digestive health concerns The prevalence of obesity and overweight in the United States coupled by the increased risk of gastrointestinal diseases related to obesity raises serious implications for the health of Americans. Researchers identify gene responsible for rare childhood disease The chromosomal abnormality that causes a rare, but often fatal, disorder that affects infants has been identified by researchers at the University of California, San Diego School of Medicine, who happened to treat two young children with the disease in San Diego - two of perhaps a dozen children in the entire country diagnosed with the disorder. Complexity of Crohn's disease revealed as 'gene' count tops 30 New research has trebled the number of genetic regions known to be implicated in Crohn's disease, a form of inflammatory bowel disease, to over thirty. International team identifies 21 new genetic risk factors for Crohn's disease An international consortium of Crohn's disease researchers has combined data from three independent studies to identify 21 new genetic variants associated with the inflammatory bowel disorder, bringing the total number of risk factors to 32. Choice of hospital impacts outcomes for inflammatory bowel disease surgery Hospitals with higher annual volumes of patients with inflammatory bowel disease (IBD) who undergo surgery have lower in-hospital mortality rates than hospitals with lower volumes of IBD patients, according to a new study by researchers at the Medical College of Wisconsin in Milwaukee. Study Underway to Find an Alternative Cure for Crohn's Disease and Ulcerative Colitis Two research studies evaluating dietary changes and complementary medicine for the treatment of inflammatory bowel diseases (IBD) have been launched at Rush University Medical Center. LIAI Researchers Discover New Cellular Mechanism That Will Significantly Advance Vaccine Development La Jolla Institute for Allergy & Immunology (LIAI) scientists have discovered one for the textbooks. Their finding, reported Friday in the scientific journal Immunity, illuminates a new, previously unknown mechanism in how the body fights a virus. Prevalence of pre-cancerous masses in the colon same in patients in their 40s and 50s The prevalence of pre-cancerous masses in the colon is the same for average-risk patients who are 40 to 49 years of age and those who are 50 to 59 years of age. More Inflammatory Bowel Disease News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||